Electrophysiologic basis for the antiarrhythmic actions of ranolazine
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Ranolazine is an FDA-approved anti-anginal agent. Experimental and clinical studies have shown that ranolazine has anti-arrhythmic effects in both ventricles and atria. In the ventricles, ranolazine can suppress arrhythmias associated with acute coronary syndrome, long QT, heart failure, ischemia, and reperfusion. In atria, ranolazine effectively suppresses atrial tachyarrhythmias and fibrillation (AF). Recent studies have shown that the drug may be effective and safe in suppressing AF when used as a pill-in-the pocket approach, even in patients with structurally compromised hearts, warranting further study. The principal mechanism underlying ranolazine’s antiarrhythmic actions is thought to be primarily via inhibition of late INa in the ventricles, and via use-dependent inhibition of peak INa and IKr in the atria. Short and long term safety of ranolazine has been demonstrated in the clinic, even in patients with structural heart disease. This review summarizes the available data regarding the electrophysiological actions, and anti-arrhythmic properties of ranolazine in preclinical and clinical studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Modelling the long QT syndrome with induced pluripotent stem cells
Itzhaki, I., Maizels, L., Huber, I., Zwi-Dantsis, L., Caspi, O., Winterstern, A., Feldman, O., Gepstein, A., Arbel, G., Hammerman, H., et al. (2011) · Nature · doi:10.1038/nature09747 · Cited by 1,049
Outpatient treatment of recent-onset atrial fibrillation with the “Pill-in-the-Pocket” approach
Alboni, P., Botto, G. L., Baldi, N., Luzi, M., Russo, V., Gianfranchi, L., Marchi, P., Calzolari, M., Solano, A., Baroffio, R., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041233 · Cited by 479
Efficacy of Ranolazine in Patients With Chronic Angina
Wilson, S. R., Scirica, B. M., Braunwald, E., Murphy, S. A., Karwatowska-Prokopczuk, E., Buros, J. L., Chaitman, B. R., & Morrow, D. A. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.01.037 · Cited by 198
KIRCHHOF, P., ECKARDT, L., FRANZ, M. R., MÖNNIG, G., LOH, P., WEDEKIND, H., SCHULZE‐BAHR, E., BREITHARDT, G., & HAVERKAMP, W. (2003) · Journal of Cardiovascular Electrophysiology · doi:10.1046/j.1540-8167.2003.03165.x · Cited by 124
Scirica, B. M., Braunwald, E., Belardinelli, L., Hedgepeth, C. M., Spinar, J., Wang, W., Qin, J., Karwatowska-Prokopczuk, E., Verheugt, F. W. A., & Morrow, D. A. (2010) · Circulation · doi:10.1161/circulationaha.110.937136 · Cited by 123
Self-citation
Cited by
De Ferrari, G. M., Maier, L. S., Mont, L., Schwartz, P. J., Simonis, G., Leschke, M., Gronda, E., Boriani, G., Darius, H., Guillamón Torán, L., et al. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.01.021 · Cited by 87
Ion channels and regulation of insulin secretion in human β-cells: a computational systems analysis
Fridlyand, L. E., Jacobson, D. A., & Philipson, L. H. (2013) · Islets · doi:10.4161/isl.24166 · Cited by 78
Metadata
- Authors
- Antzelevitch, C., Burashnikov, A., Sicouri, S., & Belardinelli, L.
- Venue
- Heart Rhythm
- Publisher
- Elsevier BV
- Published
- 2011-08
- Volume
- 8
- Issue
- 8
- Pages
- 1281-1290
- ISSN
- 1547-5271 (ISSN-L)
- OpenAlex
- W2014113446
- Cited by
- 235
- References
- 5
- FWCI
- 18.05
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.